Request Information

Auris Health Celebrates 1,000 Cases with the Monarch™ Platform

Aug 26 2019


REDWOOD CITY – August 22, 2019 – Auris Health, Inc., part of Johnson & Johnson Medical Devices Companies, today announced that physicians have performed over 1,000 bronchoscopic procedures using the Monarch™ Platform. Auris gained FDA clearance for diagnostic and therapeutic bronchoscopic procedures on the Monarch Platform in the Spring of 2018.

“We are grateful for the physicians who routinely use the Monarch Platform who aim to detect lung cancer more accurately and earlier, and helped us reach this exciting and significant milestone,” said Eric Davidson, Vice President Marketing and Sales. “The rapid adoption of the technology demonstrates that Monarch helps overcome the limitations of current, manual bronchoscopic technology in the diagnosis of lung disease.”

The Monarch Platform is designed to help physicians diagnose lung nodules when they are small and more easily treated. It has a dedicated camera and instrument channel that allow continuous vision throughout the entire procedure, enabling physicians to biopsy lung nodules that historically have been very difficult to reach.

Auris’ goal is to enable more-accurate diagnosis, and eventually treatment, of small and hard-to-reach nodules in the periphery of the lung. Lung cancer is the leading cause of cancer deaths worldwide, representing more patient deaths each year than prostate, breast, and colon cancers combined. Auris’ goal is to transform the diagnosis of lung disease and save lives. This is only the beginning.

About Auris Health, Inc.
Auris Health is pioneering the next era of medical intervention by developing platforms that enhance physician capabilities, evolve minimally invasive techniques, and create new categories of care that redefine optimal patient outcomes. The company is committed to transforming medical intervention by integrating robotics, micro-instrumentation, endoscope design, sensing, and data science into one platform. Every element of our technology is driven by patient-specific design aimed at maintaining the integrity of the human body. Learn more at www.aurishealth.com.

AURIS and MONARCH are trademarks and/or registered trademarks of Auris Health, Inc. in the United States and in other countries. All other trademarks and product names used herein are the property of their respective owners.

About Johnson & Johnson Medical Devices Companies
At Johnson & Johnson Medical Devices Companies, we are helping people live their best lives. Building on more than a century of expertise, we tackle pressing healthcare challenges, and take bold steps that lead to new standards of care while improving people’s healthcare experiences. In surgery, orthopaedics, vision and interventional solutions, we are helping to save lives and paving the way to a healthier future for everyone, everywhere.
[Footnote to first mention of JJMDC in press release text]: * The Johnson & Johnson Medical Devices Companies comprise the surgery, orthopaedics, vision and interventional solutions businesses within Johnson & Johnson’s Medical Devices segment.


Back to all Press Releases